Overlooked potential of positrons in cancer therapy

Abstract Positron (β+) emitting radionuclides have been used for positron emission tomography (PET) imaging in diagnostic medicine since its development in the 1950s. Development of a fluorinated glucose analog, fluorodeoxyglucose, labelled with a β+ emitter fluorine-18 (18F-FDG), made it possible t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Takanori Hioki, Yaser H. Gholami, Kelly J. McKelvey, Alireza Aslani, Harry Marquis, Enid M. Eslick, Kathy P. Willowson, Viive M. Howell, Dale L. Bailey
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ea60cf303261425688fef7141cb44b96
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!